Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component
Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic c...
Saved in:
Published in | Journal of clinical medicine Vol. 8; no. 11; p. 1961 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI
13.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of “A” allele of rs4553808, “G” allele of rs62182595, “G” allele of rs16840252, and “C” allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.462, 95%CI: 1.619–3.742, p = 0.008; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions. |
---|---|
AbstractList | Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of “A” allele of rs4553808, “G” allele of rs62182595, “G” allele of rs16840252, and “C” allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584–3.508,
p
= 0.02; OR = 2.357, 95%CI: 1.584–3.508,
p
= 0.02; OR = 2.462, 95%CI: 1.619–3.742,
p
= 0.008; OR = 2.357, 95%CI: 1.584–3.508,
p
= 0.02; OR = 2.357, 95%CI: 1.584–3.508,
p
= 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions. Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of "A" allele of rs4553808, "G" allele of rs62182595, "G" allele of rs16840252, and "C" allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.462, 95%CI: 1.619-3.742, p = 0.008; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions.Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of "A" allele of rs4553808, "G" allele of rs62182595, "G" allele of rs16840252, and "C" allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.462, 95%CI: 1.619-3.742, p = 0.008; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions. Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of “A” allele of rs4553808, “G” allele of rs62182595, “G” allele of rs16840252, and “C” allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.462, 95%CI: 1.619–3.742, p = 0.008; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions. Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of "A" allele of rs4553808, "G" allele of rs62182595, "G" allele of rs16840252, and "C" allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584-3.508, = 0.02; OR = 2.357, 95%CI: 1.584-3.508, = 0.02; OR = 2.462, 95%CI: 1.619-3.742, = 0.008; OR = 2.357, 95%CI: 1.584-3.508, = 0.02; OR = 2.357, 95%CI: 1.584-3.508, = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions. |
Author | Wang, Wei-Ting Wen, Ying-Hao Chiueh, Tzong-Shi Chen, Ding-Ping Lin, Wei-Tzu |
AuthorAffiliation | 2 Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan 1 Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; b9209011@cgmh.org.tw (Y.-H.W.); berry0908@cgmh.org.tw (W.-T.L.); s1223@adm.cgmh.org.tw (W.-T.W.); drche0523@cloud.cgmh.org.tw (T.-S.C.) 4 Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan 33302, Taiwan 3 Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan |
AuthorAffiliation_xml | – name: 1 Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; b9209011@cgmh.org.tw (Y.-H.W.); berry0908@cgmh.org.tw (W.-T.L.); s1223@adm.cgmh.org.tw (W.-T.W.); drche0523@cloud.cgmh.org.tw (T.-S.C.) – name: 2 Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan – name: 3 Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan – name: 4 Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan 33302, Taiwan |
Author_xml | – sequence: 1 givenname: Ying-Hao surname: Wen fullname: Wen, Ying-Hao – sequence: 2 givenname: Wei-Tzu surname: Lin fullname: Lin, Wei-Tzu – sequence: 3 givenname: Wei-Ting surname: Wang fullname: Wang, Wei-Ting – sequence: 4 givenname: Tzong-Shi surname: Chiueh fullname: Chiueh, Tzong-Shi – sequence: 5 givenname: Ding-Ping surname: Chen fullname: Chen, Ding-Ping |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31766247$$D View this record in MEDLINE/PubMed |
BookMark | eNptkV1PHCEYhUljU6160x_QcGlMtvIxM8CNybpRa7JJjdleE5Z56WJnYIUZjf9e1LVaIzcQOOc55Lxf0VaIARD6RskPzhU5ura9pJSqhn5CO4wIMSFc8q035220n_M1KUvKilHxBW1zKpqGVWIHxWnO0Xoz-BhwdHi2mE8rfA4B8GXs7vuY1iufe3znhxVeJBOyG_Oj9gqMfTIZN0DCF2FzXxhzGP_GBO1oocUnXYwtnsV-Xf4dhj302Zkuw_5m30W_z04Xs5-T-a_zi9l0PrFcyGGi-FICq1oKUqklo5Iwy0lDWsekIUqpGhrhOHFMQM2MqeumpsxJbi2taWP5Ljp-5q7HZQ-tLdHJdHqdfG_SvY7G6_9fgl_pP_FWN4oypqoCONgAUrwZIQ-699lC15kAccyacSoFl6XVIv3-NutfyEvLRUCeBTbFnBM4bf3wVHmJ9p2mRD_OUr_OslgO31leqB-IHwBAN5_v |
CitedBy_id | crossref_primary_10_3389_fimmu_2022_946456 crossref_primary_10_1038_s41598_022_10631_z crossref_primary_10_3390_jcm10040871 crossref_primary_10_3390_jcm9030877 crossref_primary_10_5937_mp72_32455 crossref_primary_10_3389_fimmu_2023_1123832 crossref_primary_10_3390_ijms252212327 |
Cites_doi | 10.1016/j.humimm.2010.11.008 10.1038/sj.gene.6363752 10.1182/blood-2007-08-106385 10.1016/S0076-6879(06)19007-2 10.1111/sji.12409 10.1002/art.24181 10.1111/j.1600-065X.2009.00781.x 10.1101/gad.308619.117 10.1038/nm.3746 10.18632/oncotarget.23136 10.1146/annurev.immunol.24.021605.090535 10.1016/j.transci.2010.05.011 10.4103/0019-5049.144650 10.1097/00129804-200405000-00004 10.1371/journal.pone.0070824 10.1159/000489953 10.4103/2141-9248.157498 10.3109/08820139.2013.879594 10.18632/oncotarget.8714 10.1080/10245332.2018.1530179 10.1111/j.1423-0410.2011.01474.x 10.1016/j.cca.2009.03.037 10.2147/OTT.S173421 10.1161/01.CIR.97.6.562 10.1111/j.1365-2796.2007.01879.x 10.1007/s00432-018-2578-8 10.3109/10408369109106870 10.1056/NEJM199409083311001 10.1007/s12020-016-1096-1 10.1101/cshperspect.a034728 10.1016/j.cca.2017.09.010 10.1038/sj.bmt.1705850 |
ContentType | Journal Article |
Copyright | 2019 by the authors. 2019 |
Copyright_xml | – notice: 2019 by the authors. 2019 |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.3390/jcm8111961 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2077-0383 |
ExternalDocumentID | PMC6912294 31766247 10_3390_jcm8111961 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Chang Gung Memorial Hospital grantid: CMRPG3F0442 , CMRPG3I0261 and BMRPA81 |
GroupedDBID | 53G 5VS 7X7 8FI 8FJ AADQD AAFWJ AAYXX ABDBF ABUWG ACUHS ADBBV AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION DIK FYUFA HMCUK HYE IAO IHR ITC KQ8 M48 MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY RPM UKHRP GROUPED_DOAJ NPM 7X8 5PM |
ID | FETCH-LOGICAL-c378t-93b8e24d1e899b21802c3060df28a09995e67f30f27e52aa556512f83cc1516c3 |
IEDL.DBID | M48 |
ISSN | 2077-0383 |
IngestDate | Thu Aug 21 13:52:21 EDT 2025 Thu Jul 10 17:10:15 EDT 2025 Thu Jan 02 23:00:56 EST 2025 Tue Jul 01 04:33:54 EDT 2025 Thu Apr 24 23:03:48 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | CTLA4 gene polymorphism leukoreduction transfusion reaction |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c378t-93b8e24d1e899b21802c3060df28a09995e67f30f27e52aa556512f83cc1516c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/jcm8111961 |
PMID | 31766247 |
PQID | 2318738000 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912294 proquest_miscellaneous_2318738000 pubmed_primary_31766247 crossref_citationtrail_10_3390_jcm8111961 crossref_primary_10_3390_jcm8111961 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20191113 |
PublicationDateYYYYMMDD | 2019-11-13 |
PublicationDate_xml | – month: 11 year: 2019 text: 20191113 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Journal of clinical medicine |
PublicationTitleAlternate | J Clin Med |
PublicationYear | 2019 |
Publisher | MDPI |
Publisher_xml | – name: MDPI |
References | Chen (ref_13) 2017; 474 Frydecka (ref_29) 2017; 55 Mayr (ref_38) 2018; 11 Sahu (ref_3) 2014; 58 Ortolano (ref_7) 2004; 27 Encuentra (ref_21) 2007; 110 Azarian (ref_22) 2007; 11 Wu (ref_17) 2009; 403 Rajesh (ref_12) 2015; 5 Hawley (ref_14) 2006; 419 ref_31 Tsai (ref_1) 2010; 43 Brunet (ref_19) 2011; 18 Guo (ref_30) 2016; 26 Fang (ref_32) 2018; 47 Hammrich (ref_37) 2018; 144 Hermans (ref_11) 1998; 97 Yao (ref_35) 2019; 24 Mempel (ref_8) 1993; 31 Chang (ref_10) 2018; 9 Wang (ref_27) 2008; 263 Zou (ref_33) 2018; 11 Li (ref_15) 2009; 229 Sellami (ref_18) 2011; 72 ref_23 Mikhaylichenko (ref_25) 2018; 32 Tang (ref_34) 2016; 83 Schubert (ref_36) 2014; 20 Ligers (ref_28) 2001; 2 Heddle (ref_5) 1994; 331 Vannucchi (ref_20) 2007; 40 ref_2 Brown (ref_6) 2011; 101 Lichtiger (ref_9) 1991; 28 Karimi (ref_16) 2014; 43 Teft (ref_24) 2006; 24 Kolar (ref_26) 2009; 60 ref_4 |
References_xml | – volume: 72 start-page: 139 year: 2011 ident: ref_18 article-title: Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant publication-title: Hum. Immunol. doi: 10.1016/j.humimm.2010.11.008 – volume: 2 start-page: 145 year: 2001 ident: ref_28 article-title: CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms publication-title: Genes Immun. doi: 10.1038/sj.gene.6363752 – volume: 11 start-page: 4623 year: 2007 ident: ref_22 article-title: Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations publication-title: Blood doi: 10.1182/blood-2007-08-106385 – volume: 419 start-page: 149 year: 2006 ident: ref_14 article-title: Hematopoietic Stem Cells publication-title: Methods Enzym. doi: 10.1016/S0076-6879(06)19007-2 – volume: 83 start-page: 212 year: 2016 ident: ref_34 article-title: Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma publication-title: Scand. J. Immunol. doi: 10.1111/sji.12409 – volume: 60 start-page: 123 year: 2009 ident: ref_26 article-title: CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice publication-title: Arthritis Rheum. doi: 10.1002/art.24181 – volume: 229 start-page: 271 year: 2009 ident: ref_15 article-title: Costimulatory pathways in transplantation: Challenges and new developments publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2009.00781.x – volume: 32 start-page: 42 year: 2018 ident: ref_25 article-title: The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription publication-title: Genes Dev. doi: 10.1101/gad.308619.117 – volume: 20 start-page: 1410 year: 2014 ident: ref_36 article-title: Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations publication-title: Nat. Med. doi: 10.1038/nm.3746 – volume: 110 start-page: 461 year: 2007 ident: ref_21 article-title: CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA identical sibling donors publication-title: Blood J. Am. Soc. Hematol. – volume: 9 start-page: 4385 year: 2018 ident: ref_10 article-title: Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: The impact of prestorage versus poststorage leukoreduction publication-title: Oncotarget doi: 10.18632/oncotarget.23136 – volume: 24 start-page: 65 year: 2006 ident: ref_24 article-title: A molecular perspective of CTLA-4 function publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.24.021605.090535 – volume: 43 start-page: 69 year: 2010 ident: ref_1 article-title: Perfusion vs. oxygen delivery in transfusion with “fresh” and “old” red blood cells: The experimental evidence publication-title: Transfus. Apher. Sci. doi: 10.1016/j.transci.2010.05.011 – volume: 58 start-page: 543 year: 2014 ident: ref_3 article-title: Adverse events related to blood transfusion publication-title: Indian J. Anaesth. doi: 10.4103/0019-5049.144650 – volume: 27 start-page: 157 year: 2004 ident: ref_7 article-title: Contamination control in nursing with filtration: Part 2: Emerging rationale for bedside (final) filtration of prestorage leukocyte-reduced blood products publication-title: J. Infus. Nurs. doi: 10.1097/00129804-200405000-00004 – ident: ref_31 doi: 10.1371/journal.pone.0070824 – volume: 47 start-page: 414 year: 2018 ident: ref_32 article-title: Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies publication-title: Cell. Physiol. Biochem. doi: 10.1159/000489953 – volume: 5 start-page: 185 year: 2015 ident: ref_12 article-title: Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital publication-title: Ann. Med. Health Sci. Res. doi: 10.4103/2141-9248.157498 – volume: 43 start-page: 391 year: 2014 ident: ref_16 article-title: Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients publication-title: Immunol. Investig. doi: 10.3109/08820139.2013.879594 – volume: 26 start-page: 23088 year: 2016 ident: ref_30 article-title: Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients publication-title: Oncotarget doi: 10.18632/oncotarget.8714 – ident: ref_23 – volume: 24 start-page: 123 year: 2019 ident: ref_35 article-title: Association of cytotoxic T-lymphocyte antigen 4 gene with immune thrombocytopenia in Chinese Han children publication-title: Hematology doi: 10.1080/10245332.2018.1530179 – volume: 101 start-page: 93 year: 2011 ident: ref_6 article-title: Clinical relevance of the HLA system in blood transfusion publication-title: Vox Sang. doi: 10.1111/j.1423-0410.2011.01474.x – volume: 403 start-page: 229 year: 2009 ident: ref_17 article-title: Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation publication-title: Clin. Chim. Acta doi: 10.1016/j.cca.2009.03.037 – ident: ref_4 – volume: 11 start-page: 4609 year: 2018 ident: ref_33 article-title: CTLA4 tagging polymorphisms and risk of colorectal cancer: A case–control study involving 2,306 subjects publication-title: Onco Targets Ther. doi: 10.2147/OTT.S173421 – volume: 97 start-page: 562 year: 1998 ident: ref_11 article-title: Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial publication-title: Circulation doi: 10.1161/01.CIR.97.6.562 – ident: ref_2 – volume: 263 start-page: 61 year: 2008 ident: ref_27 article-title: Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis publication-title: J. Intern. Med. doi: 10.1111/j.1365-2796.2007.01879.x – volume: 144 start-page: 587 year: 2018 ident: ref_37 article-title: CTLA-4 polymorphisms: Influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation publication-title: J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-018-2578-8 – volume: 28 start-page: 387 year: 1991 ident: ref_9 article-title: Leukocyte-poor blood components: Issues and indications publication-title: Crit. Rev. Clin. Lab. Sci. doi: 10.3109/10408369109106870 – volume: 331 start-page: 625 year: 1994 ident: ref_5 article-title: The role of the plasma from platelet concentrates in transfusion reactions publication-title: N. Eng. J. Med. doi: 10.1056/NEJM199409083311001 – volume: 55 start-page: 186 year: 2017 ident: ref_29 article-title: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease publication-title: Endocrine doi: 10.1007/s12020-016-1096-1 – volume: 11 start-page: a034728 year: 2018 ident: ref_38 article-title: What Are 3′ UTRs Doing? publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a034728 – volume: 18 start-page: 100 year: 2011 ident: ref_19 article-title: Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors publication-title: Biol. Blood Marrow Transplant. – volume: 474 start-page: 120 year: 2017 ident: ref_13 article-title: Human platelet antigens are associated with febrile non-hemolytic transfusion reactions publication-title: Clin. Chim. Acta doi: 10.1016/j.cca.2017.09.010 – volume: 31 start-page: 81 year: 1993 ident: ref_8 article-title: Substitution of thrombocyte concentrates in polytransfused patients publication-title: Beitr. Infusionsther. – volume: 40 start-page: 1001 year: 2007 ident: ref_20 article-title: Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation publication-title: Bone Marrow Transplant. doi: 10.1038/sj.bmt.1705850 |
SSID | ssj0000884217 |
Score | 2.145495 |
Snippet | Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1961 |
Title | Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31766247 https://www.proquest.com/docview/2318738000 https://pubmed.ncbi.nlm.nih.gov/PMC6912294 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB5RkKpeKgp9bEtXruDCIa1jO7FzQBUgEK0AIcRKe4vWji1olwT2IcG_ZybJblng0GtiO9ZM7Pk-P74B2Ao68ZmwPOI2JEhQXIhsKELkUpVy4xBjh_qA7Gl61FO_-0l_CWb5O1sDjl-kdpRPqjcafr-7vf-JA36HGCdS9h9_3LXBIZsRC1rBiKQpk8FJC_PrGdkYJerku4JrHXFkZY1S6ZPqi7HpGeB8em7yUSA6XIW3LYJku43L38GSL9fg9Um7R74O1SOLsyqw_YvjXcVIXpqdVUOk-mjZq_E1oxVYVoeqMKUlM3bum0sOrM4bzn6V7XNs49hP_1YjUnn1Bdujs-6MJpKqxC6-h97hwcX-UdSmVYic1GYSZdIaL1QRe-RaVpAEnEPiwIsgzIAAY-JTHSQPQvtEDAYJYr5YBCOdQ3iQOvkBlkv8wCdg3FkXglXGFgF5Xma4DLFULrEqsc4VHdieGTR3reY4pb4Y5sg9yPj5P-N3YHNe9qZR2nix1LeZX3IcCLS7MSh9NR3nCFSNloh_eQc-Nn6atyNJBlMo3QG94MF5ARLZXnxTXl3WYttpFguRqc__1bsv8AYBVUZ3FWO5AcuT0dR_RdAysV14pfu6Cyt7B6dn5936_3wAk1_vHw |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+CTLA4+Gene+Polymorphism+with+Transfusion+Reaction+after+Infusion+of+Leukoreduced+Blood+Component&rft.jtitle=Journal+of+clinical+medicine&rft.au=Wen%2C+Ying-Hao&rft.au=Lin%2C+Wei-Tzu&rft.au=Wang%2C+Wei-Ting&rft.au=Chiueh%2C+Tzong-Shi&rft.date=2019-11-13&rft.issn=2077-0383&rft.eissn=2077-0383&rft.volume=8&rft.issue=11&rft.spage=1961&rft_id=info:doi/10.3390%2Fjcm8111961&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_jcm8111961 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2077-0383&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2077-0383&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2077-0383&client=summon |